135 related articles for article (PubMed ID: 11228117)
1. Mortality in elderly men with low psychosocial coping resources using anxiolytic-hypnotic drugs.
Merlo J; Ostergren PO; Månsson NO; Hanson BS; Ranstam J; Blennow G; Isacsson SO; Melander A
Scand J Public Health; 2000 Dec; 28(4):294-7. PubMed ID: 11228117
[TBL] [Abstract][Full Text] [Related]
2. Use of anxiolytic or hypnotic drugs and total mortality in a general middle-aged population.
Hausken AM; Skurtveit S; Tverdal A
Pharmacoepidemiol Drug Saf; 2007 Aug; 16(8):913-8. PubMed ID: 17486666
[TBL] [Abstract][Full Text] [Related]
3. Neighborhood social participation, use of anxiolytic-hypnotic drugs, and women's propensity for disability pension: a multilevel analysis.
Johnell K; Månsson NO; Sundquist J; Melander A; Blennow G; Merlo J
Scand J Public Health; 2006; 34(1):41-8. PubMed ID: 16449043
[TBL] [Abstract][Full Text] [Related]
4. Infertility and assisted reproduction in Denmark. Epidemiology and psychosocial consequences.
Schmidt L
Dan Med Bull; 2006 Nov; 53(4):390-417. PubMed ID: 17150146
[TBL] [Abstract][Full Text] [Related]
5. Anxiolytic-hypnotic drug use associated with trust, social participation, and the miniaturization of community: a multilevel analysis.
Johnell K; Lindström M; Melander A; Sundquist J; Eriksson C; Merlo J
Soc Sci Med; 2006 Mar; 62(5):1205-14. PubMed ID: 16115711
[TBL] [Abstract][Full Text] [Related]
6. Anxiolytic, hypnotic and sedative medication use in Australia.
Hollingworth SA; Siskind DJ
Pharmacoepidemiol Drug Saf; 2010 Mar; 19(3):280-8. PubMed ID: 20073039
[TBL] [Abstract][Full Text] [Related]
7. The effect of social relationships on survival in elderly residents of a Southern European community: a cohort study.
Rodriguez-Laso A; Zunzunegui MV; Otero A
BMC Geriatr; 2007 Aug; 7():19. PubMed ID: 17678536
[TBL] [Abstract][Full Text] [Related]
8. [Epidemiology of the use of anxiolytic and hypnotic drugs in France and in the world].
Pélissolo A; Boyer P; Lépine JP; Bisserbe JC
Encephale; 1996; 22(3):187-96. PubMed ID: 8767047
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for coronary heart disease in different socioeconomic groups of Lithuania and Sweden--the LiVicordia Study.
Kristenson M; Kucinskiene Z; Bergdahl B; Orth-Gomér K
Scand J Public Health; 2001 Jun; 29(2):140-50. PubMed ID: 11484867
[TBL] [Abstract][Full Text] [Related]
10. Is usage of hypnotics associated with mortality?
Mallon L; Broman JE; Hetta J
Sleep Med; 2009 Mar; 10(3):279-86. PubMed ID: 19269892
[TBL] [Abstract][Full Text] [Related]
11. Perceived stress and cause-specific mortality among men and women: results from a prospective cohort study.
Nielsen NR; Kristensen TS; Schnohr P; Grønbaek M
Am J Epidemiol; 2008 Sep; 168(5):481-91; discussion 492-6. PubMed ID: 18611955
[TBL] [Abstract][Full Text] [Related]
12. What is the point of guidelines? Benzodiazepine and z-hypnotic use by an elderly population.
Neutel CI; Skurtveit S; Berg C
Sleep Med; 2012 Aug; 13(7):893-7. PubMed ID: 22704401
[TBL] [Abstract][Full Text] [Related]
13. Relationship between plasma lipids and all-cause mortality in nondemented elderly.
Schupf N; Costa R; Luchsinger J; Tang MX; Lee JH; Mayeux R
J Am Geriatr Soc; 2005 Feb; 53(2):219-26. PubMed ID: 15673344
[TBL] [Abstract][Full Text] [Related]
14. Increased risk of ischaemic heart disease mortality in elderly men using anxiolytics-hypnotics and analgesics. Results of the 10-year follow-up of the prospective population study "Men born in 1914", Malmo, Sweden.
Merlo J; Hedblad B; Ogren M; Ranstam J; Ostergren PO; Ekedahl A; Hanson BS; Isacsson SO; Liedholm H; Melander A
Eur J Clin Pharmacol; 1996; 49(4):261-5. PubMed ID: 8857070
[TBL] [Abstract][Full Text] [Related]
15. [Benzodiazepine use in the elderly: the EVA Study].
Lechevallier N; Fourrier A; Berr C
Rev Epidemiol Sante Publique; 2003 Jun; 51(3):317-26. PubMed ID: 13130212
[TBL] [Abstract][Full Text] [Related]
16. Risk factors in oral and oropharyngeal squamous cell carcinoma: a population-based case-control study in southern Sweden.
Rosenquist K
Swed Dent J Suppl; 2005; (179):1-66. PubMed ID: 16335030
[TBL] [Abstract][Full Text] [Related]
17. Quality of life and social determinants of anxiolytics and hypnotics use in women in Poland: a population-based study.
Zagozdzon P; Kolarzyk E; Marcinkowski JT
Int J Soc Psychiatry; 2013 May; 59(3):296-300. PubMed ID: 22491757
[TBL] [Abstract][Full Text] [Related]
18. Asymptomatic atherosclerosis and myocardial infarction: risk modified by ability to adapt to stressful situations. Results from prospective cohort study "Men born in 1914", Malmo, Sweden.
Andre-Petersson L; Hedblad B; Janzon L; Steen G
Med Sci Monit; 2004 Oct; 10(10):CR549-56. PubMed ID: 15448593
[TBL] [Abstract][Full Text] [Related]
19. [Anxiolytic agents and hypnotic drugs in Bretagne. Pharmaco-epidemiological study].
Nguyen JM; Allain H; Martinet JP; Beneton C; Reymann JM; Decombe R
Ann Med Interne (Paris); 1991; 142(3):163-7. PubMed ID: 1677240
[TBL] [Abstract][Full Text] [Related]
20. Trends in anxiolytic-hypnotic use and polypharmacy in Taiwan, 2002-2009: a nationwide, population-based survey.
Wang LJ; Chen YC; Chen CK; Chou WJ; Chou MC
Psychiatr Serv; 2014 Feb; 65(2):208-14. PubMed ID: 24233182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
